Agilent Technologies, Inc. announced that Sam Raha is resigning as Senior Vice President of the Company and President of the Diagnostics and Genomics Group to pursue another opportunity and will continue in his current role until December 8, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.4 USD | -0.77% | -13.44% | -6.20% |
May. 30 | A new phase for the market | |
May. 30 | UBS Cuts Price Target on Agilent Technologies to $141 From $155, Keeps Neutral Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.20% | 38.32B | |
+7.01% | 215B | |
+11.01% | 187B | |
+19.20% | 143B | |
+30.79% | 110B | |
+1.48% | 64.68B | |
+13.95% | 52.96B | |
-0.16% | 49.84B | |
+0.91% | 35.86B | |
+19.95% | 30.75B |
- Stock Market
- Equities
- A Stock
- News Agilent Technologies, Inc.
- Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group